The U.K. Society of Radiographers (SoR) has focused attention on a study suggesting that whole-body MRI scans can detect minuscule traces of multiple myeloma.
Conducted by the Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, the study involved 70 patients undergoing stem cell transplants. Participants were scanned via whole-body MRI before and after treatment. One in three patients had signs of minimal residual disease and had a median progression-free survival of just 24 months compared with 42 months for patients with no visible disease on imaging, the SoR noted.
“The study marks the first prospective attempt to evaluate the value of whole-body MRI in predicting how well multiple myeloma patients respond to treatment,” it stated.
Read the full SoR statement on the study here.
